Provider

Medical tech company Medtronic is teaming up with Nutrino, an AI powered personalized nutrition platform.

To all of the people who work with machine learning and neural networks healthcare technologies, but can’t describe exactly how the gears are turning — don’t worry, you’re not alone.

Medical tech company Medtronic has just landed FDA clearance on its Deep Brain Stimulation (DBS) Clinical Programmer and ActivaProgramming application.

The FDA has granted Isreal-based DreaMed Diabetes a de novo request for its artificial intelligence-powered software for providers managing patients with Type 1 diabetes.

In the last few years consumer genomics has grown in both its offerings and legitimacy.

DyAnsys, a medical device company specializing in the autonomic nervous system, announced this week that it has received FDA approval for a wearable auricular neurostimulation device designed to treat symptoms of opioid withdrawal.

The past month has seen a succession of publications offering support for Click Therapeutics’ digital offering for patients with major depressive disorder (MDD).

A little bit of cash paired with a wearable activity tracker could be key in motivating people with ischemic heart disease to stay active.

Patients of doctors who participated in a Veteran Affairs-run telemedicine consultation program were 54 percent more likely to survive chronic liver disease than a matched cohort of patients of non-participating doctors, according to a new retrospective study from the University of Michigan.

The Centers for Medicare and Medicaid Services will reverse a longstanding unpopular position on reimbursement for smartphone-connected continuous glucose monitors, CMS announced yesterday.